The Expertise Imperative and Compliance Technology
Access to a diverse array of specialized expert inputs drives superior decisions in every organizational context: within corporations, by investors and consultancies, and within nonprofits. When decision makers are confident of their decision inputs, they can respond more quickly and creatively to challenges and opportunities.Learn more about GLG's Compliance Framework
This page may include content provided by Council Members, your access to which is subject to the Terms of Use.
While we have made great strides in reducing needle sticks through education and newer safety needles, accidents still happen. Reporting of injuries is important, not only to identify reasons why people have these accidents (and to hopefully help them learn behaviors to minimized these...
Cerner has made large leaps in electronic charting. The addition of this package to their suite builds additional safety into their system while allowing transfuions to be administered in a safe, paperless manner.
While the results are impressive for velcade/dex vs. VAD, most would not consider VAD a standard induction regimen. Likely to be good news in the long run for Millenium, but many will want to see comparison data for velcade and thalidomide in the induction setting ...
This state of the art robotic LINAC allows for intracranial and extracranial stereotactic radiosurgery, and has exploded on the scene with excellent treatment results
Varian's flat panel is not digital fluoroscopy for treatment planning, but for image guided radiotherapy for daily treatment delivery - a big difference. This panel is for a state of the art treatment delivery techniquie
While phase I and phase II data can show promising results, the proof in concept is whether a novel agent improves over standard of care medicine. This is another example of a 'promising' drug that has not proven itself.
Advitech's launch of Dermylex will not have much of an impact on the psoriasis market. This is due to the fact that the product has minimal studies to back it up, and the company will rely on testimonials. This is not an effective way of marketing to physicians, and is difficult with patients....
Depending on the accuracy and cost of the technology, this device could be a useful and welcome tool in melanoma diagnosis. To be considered useful, the Melafind device must increase melanoma recognition without a significant false negative rate. In other words, the machines ability to catch...